Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy

Malignant melanoma is a life-threatening form of skin cancer with a low response rate to single-agent chemotherapy. Although combined therapies of metformin (MET) and doxorubicin (DOX) are effective in treating a variety of cancers, including breast cancer, their different physicochemical properties...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Mingming, Xia, Wentao, Tao, Zixuan, Zhu, Bin, Zhang, Wenxiang, Liu, Chang, Chen, Siyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996084/
https://www.ncbi.nlm.nih.gov/pubmed/33729072
http://dx.doi.org/10.1080/10717544.2021.1898703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996084/
https://www.ncbi.nlm.nih.gov/pubmed/33729072
http://dx.doi.org/10.1080/10717544.2021.1898703

Ejemplares similares